Role of Vaginal Misoprostol Prior to IUCD Insertion in Women Who Delivered Only by Elective Caesarean Section.
NCT ID: NCT03939663
Last Updated: 2019-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
210 participants
INTERVENTIONAL
2018-07-01
2019-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion
NCT03790371
Sub Lingual Misoprostol Before IUD Insertion in Women With Only Previous Cesarean Section
NCT02141321
Vaginal Misoprostol Before IUD Insertion in Women With Cesarean Scar
NCT03081442
Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion
NCT04273984
Vaginal Vs Subling Misoprost Before Iud Insertion in Women With Previous CS
NCT05204979
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo group
2 tablets vaginally
Placebo
starch pills manufactured to mimic misoprostol 200 mg tablets
misoprostol group
400 mcg vaginally
misoprostol
misoprostol 2 tablets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
misoprostol
misoprostol 2 tablets
Placebo
starch pills manufactured to mimic misoprostol 200 mg tablets
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Desires IUCD placement and able to participate.
* Negative pregnancy test.
* Willing to follow- up in 6-8 weeks for a standard IUCD follow-up visit.
* Delivered only by cesarean section.
Exclusion Criteria
* Current pregnancy.
* Uterine anomaly.
* Fibroid uterus.
* Copper allergy/Wilson's disease.
* Undiagnosed abnormal uterine bleeding.
* Cervical or uterine cancer.
* Allergy to misoprostol.
* Previous vaginal delivery.
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enas Mahmoud Mohammed Mohammed Elshahed
MBBCh.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Enas Mahmoud
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EMMMElshahed
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.